Rob and Greg kick off the episode with some discussion around news and noteworthy items across the 340B landscape, including more dialogue around CMS guidance on “JG”/”TB” modifiers (1:01), 340B in the news media (4:31), grantee recertification tips (14:13) and ongoing challenges working 340B ESP (18:39). Later in the episode, they are joined by Victoria Ferris of OptumRx and Thatcher Sloan of RxBenefits to discuss pharmacy benefit strategy as an underappreciated opportunity in the 340B space (26:23).